Stocks · Health care · Pharmaceutical Preparations

Generate Biomedicines, Inc.

GENB

United States Fiscal year ends December CIK 0002100782 Results filed 6 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (12 mo)

$150.30M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$200.74K

$200.74K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 2 sales

Net

+$150.10M

+$150.30M against sales at will